Google
WWW CareCure Forums

Go Back   CareCure Forums > SCI Community Forums > Tranverse Myelitis, Multiple Sclerosis, Non-traumatic SCI

Tranverse Myelitis, Multiple Sclerosis, Non-traumatic SCI ALS, MS, polio, stroke, and other non-traumatic causes of spinal cord injury

Reply
 
Thread Tools Display Modes
Old 08-29-2005, 09:19 PM   #1
Wise Young
Administrator
 
Wise Young's Avatar
 
Join Date: Jul 2001
Location: New Brunswick, NJ, USA
Posts: 37,988
Koh, et al. (2005). Role of GSK-3beta activity in motor neuronal cell death induced by G93A or A4V mutant hSOD1 gene.

This is of interest because lithium inhibits GSK-3.

Quote:
Koh SH, Lee YB, Kim KS, Kim HJ, Kim M, Lee YJ, Kim J, Lee KW and Kim SH (2005). Role of GSK-3beta activity in motor neuronal cell death induced by G93A or A4V mutant hSOD1 gene. Eur J Neurosci 22: 301-9. Point mutations such as G93A and A4V in the human Cu/Zn-superoxide dismutase gene (hSOD1) cause familial amyotrophic lateral sclerosis (fALS). In spite of several theories to explain the pathogenic mechanisms, the mechanism remains largely unclear. Increased activity of glycogen synthase kinase-3 (GSK-3) has recently been emphasized as an important pathogenic mechanism of neurodegenerative diseases, including Alzheimer's disease and ALS. To investigate the effects of G93A or A4V mutations on the phosphatidylinositol-3-kinase (PI3-K)/Akt and GSK-3 pathway as well as the caspase-3 pathway, VSC4.1 motoneuron cells were transfected with G93A- or A4V-mutant types of hSOD1 (G93A and A4V cells, respectively) and, 24 h after neuronal differentiation, their viability and intracellular signals, including PI3-K/Akt, GSK-3, heat shock transcription factor-1 (HSTF-1), cytochrome c, caspase-3 and poly(ADP-ribose) polymerase (PARP), were compared with those of wild type (wild cells). Furthermore, to elucidate the role of the GSK-3beta-mediated cell death mechanism, alterations of viability and intracellular signals in those mutant motoneurons were investigated after treating the cells with GSK-3beta inhibitor. Compared with wild cells, viability was greatly reduced in the G93A and A4V cells. However, the treatment of G93A and A4V cells with GSK-3beta inhibitor increased their viability by activating HSTF-1 and by reducing cytochrome c release, caspase-3 activation and PARP cleavage. However, the treatment did not affect the expression of PI3-K/Akt and GSK-3beta. These results suggest that the G93A or A4V mutations inhibit PI3-K/Akt and activate GSK-3beta and caspase-3, thus becoming vulnerable to oxidative stress, and that the GSK-3beta-mediated cell death mechanism is important in G93A and A4V cell death. Department of Neurology, Institute of Biomedical Science, College of Medicine, Hanyang University, #17 Haengdang-dong, Seongdong-gu, Seoul, 133-791, Korea. kimsh1@hanyang.ac.kr http://www.ncbi.nlm.nih.gov/entrez/q..._uids=16045483
Wise Young is offline   Reply With Quote
Reply

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump

Similar Threads
Thread Thread Starter Forum Replies Last Post
LANCET´S ARTICLE KIM Cure 2 10-04-2002 09:52 AM
Leukemia gene therapy may be relevant for stem cell transplant therapy Wise Young Cure 0 05-08-2002 07:49 AM
Wu, et al. (2001): A gene PTEN which suppresses tumor cells also controls stem cell growth Wise Young Stem Cell Research 1 11-28-2001 05:30 AM
Gene Controls Neural Stem Cell Growth Max Cure 0 11-09-2001 10:45 AM
NFG daniela Cure 1 08-25-2001 09:43 AM


All times are GMT -4. The time now is 05:04 AM.



"CC Wiki" powered by VaultWiki v2.5.0.
Copyright © 2008 - 2013, Cracked Egg Studios.